Biosensors & bioelectronics · 2014
A signal-off sandwich photoelectrochemical immunosensor using TiO2 coupled with CdS as the photoactive matrix and copper (II) ion as inhibitor.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Liu Yixin, Li Rongxia, Gao Picheng, Zhang Yong, Ma Hongmin, Yang Jiaojiao, Du Bin, Wei Qin
Аннотация
In this work, a novel sandwich photoelectrochemical (PEC) biosensor was developed based on a signal-off strategy using TiO2 coupled with CdS quantum dots (QDs) as the photoactive matrix and copper (II) ion (Cu(2+)) as inhibitor. TiO2/CdS modified indium tin oxide (ITO) electrode was employed for primary antibody (Ab1) immobilization and the subsequent sandwich-type antibody-antigen (Ab-Ag) affinity interactions. Flower-like copper oxide (CuO) was used as labels of secondary antibody (Ab2) and immobilized on the modified electrode via specific affinity interactions between Ab2 and Ag. Cu(2+) was released by dissolving CuO with HCl, and then reacted with CdS to form CuxS (x=1, 2), which would create new energy levels for electron-hole recombination and resulted in a decrease of the photocurrent. CuO, as the labels of Ab2, was first applied in PEC biosensor based on the signal-off strategy of the Cu(2+) for CdS. Greatly enhanced sensitivity was achieved through the coupling of CdS QDs with TiO2. Besides, the introduction of polythiophene (PT-Cl) on the surface of TiO2 made the PEC signal more stable. Under 405nm irradiation at 0.1V, the PEC biosensor for H-IgG determination exhibited a linear range from 0.1pgmL(-1) to 100ngmL(-1) with a low detection limit of 0.03pgmL(-1). The proposed biosensor showed high sensitivity, stability and selectivity, which opens up a new promising signal-off PEC platform for future bioassay.